DOWNLOAD

THE ARTICLE 

DOWNLOAD NOW!

All Rights Reserved. Forward ® 2017

EBD Group Inc., 2032 Corte Del Nogal, Ste. 120, 92011 Carlsbad, CA


Join us at the inaugural 

Cell & Gene Exchange

May 22–23, 2017 // Washington DC


The event brings together the regulatory, business and patient advocacy communities to enable the development of meaningful partnerships to advance the cell and gene therapy sector.

Biopharma companies are working with patient advocacy foundations sooner—and closer—than ever before. As a result, companies are gaining insights very early in the therapeutic development stage that can streamline and speed scientific advances and regulatory approval.

Read the full article

Biotech Engages Patients Earlier   than Ever

Advances in Cell and Gene Therapies Provide   New Opportunities

Industry leaders and patient advocacy groups collaborate to advance R&D.

Learn more about the event >>

More than 800 clinical trials are underway in the regenerative medicine sector resulting in scientific advances in areas of unmet medical need, especially in rare diseases. Read more about the important role of partnerships in advancing the sector.

#CGX17

Fix the following errors:
Hide